US FDA's Consumer Health Oversight Absent From Appropriators’ Request For COVID-19 Assessment

At 90 And Counting, Will Supplement Warnings Merit Mention In Response?

House appropriators don’t mention the consumer health market in requesting a report on FDA’s response to COVID-19, but the agency’s frequent warnings about products marketed with unlawful claims could merit mentioning. Encouraging accelerated production of hand sanitizers while also ensuring the additional supplies are safe is another component of its COVID-19 response that could be covered in an assessment of its response to the pandemic.

Test result of a Corona test. Hand turns a dice and changes the expression "positive COVID19" to "negative COVID19".

US House appropriators don’t mention the consumer health market in requesting a report on the Food and Drug Administration’s response to the COVID-19 pandemic, but the agency’s frequent warnings about products marketed with unlawful claims could merit mentioning in its report.

Encouraging accelerated product of hand sanitizers while also ensuring the additional supplies are safe is another component of its COVID-19...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Policy & Regulation